BOT fundamentals
An in-depth look to BOTANIX PHARMACEUTICALS LTD operating, investing, and financing activities
BOT free cash flow for H1 24 is -3.8 M AUD. For 2023, BOT free cash flow was -12.08 M AUD and operating cash flow was -12.07 M AUD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: AUD
TTM